UCB PHARMA
Scheduling

UCB PHARMA Enhance drug development project management

The Company & context

UCB is a leading global biopharmaceutical company dedicated to the research, development and commercialization of innovative pharmaceutical and biotechnology products (R&D headcount: over 1,700 people). UCB growth accelerated through the acquisition of Celltech (2004) and Schwarz Pharma (2007)

The Challenge

schema5.jpg
  • Enhance collaboration & communication between the different stakeholders of drug development projects
  • Implement a shared & up-to-date repository to plan & track the development activities
  • Better anticipate bottlenecks of a growing development portfolio
  • Provide global reporting

The Solution

Design & implement an Enterprise Project Management System, based on OPX2:

  • Cross functional planning linked to function planning (Pre Clinical, Clinical…) & integrated with CTMS (IMPACT)
  • Reporting for Management, Functions & project team
  • “What if” scenarios

Roll-out & training of the users for Belgium, UK & US sites

ContactPrint

Portfolio Management

Enterprise Project Management system

Capacity planning / Workload schedule / Resources assignment

Scheduling

  • UCB PHARMA

ORESYS has recently provided Project Management services in the Pharmaceutical Industry for the following clients :

flag_usa.gif USA

BIOMERIEUX, GALDERMA, JOHNSON & JOHNSON, MERIAL, ORTHO-MC NEIL JANSSEN SCIENTIFIC AFFAIRS, SANOFI-AVENTIS, SANOFI-PASTEUR, UCB

flag_europe.gif Europe

BELGIUM: JOHNSON & JOHNSON, UCB PHARMA, SOLVAY

FRANCE: IPSEN, SANOFI-AVENTIS, SANOFI PASTEUR, SERVIER, MAPI-NAXIS, BIOMERIEUX

GERMANY: SANOFI-AVENTIS, SCHWARZ PHARMA

ITALY: SERVIER

NETHERLANDS: BIOMERIEUX, JOHNSON & JOHNSON

SPAIN: IPSEN

SWITZERLAND: NOVARTIS

UK: IPSEN, JOHNSON & JOHNSON, NOVARTIS, UCB PHARMA

ORESYS has also provided Project Management services in many other industries

Contact us to find out more about our credentials